NDC 0002-8233
Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 KwikPen
Insulin Lispro
Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 KwikPen is a Subcutaneous Injection, Suspension in the Human Prescription Drug category. It is labeled and distributed by Eli Lilly And Company. The primary component is Insulin Lispro.
| Product ID | 0002-8233_14062960-5954-4bb0-b1b3-66322c8eec8a |
| NDC | 0002-8233 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 KwikPen |
| Generic Name | Insulin Lispro |
| Dosage Form | Injection, Suspension |
| Route of Administration | SUBCUTANEOUS |
| Marketing Start Date | 2020-02-12 |
| Marketing Category | BLA / NDA AUTHORIZED GENERIC |
| Application Number | BLA021017 |
| Labeler Name | Eli Lilly and Company |
| Substance Name | INSULIN LISPRO |
| Active Ingredient Strength | 100 [iU]/mL |
| Pharm Classes | Insulin [Chemical/Ingredient],Insulin Analog [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |